These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Characterization of [3H]yohimbine binding to putative alpha-2 adrenergic receptors in neonatal rat lung.
    Author: Latifpour J, Jones SB, Bylund DB.
    Journal: J Pharmacol Exp Ther; 1982 Dec; 223(3):606-11. PubMed ID: 6292392.
    Abstract:
    In contrast to the adult rat lung, which lacks alpha-2 adrenergic receptor binding sites, the neonatal rat lung had a high density of [3H]yohimbine binding sites. The binding of this alpha-2 antagonist was saturable, reversible and stereospecific. Steady-state binding was reached by 15 min at 23 degrees C, and the association and dissociation rate constants were 0.17 min-1nM-1 and 0.30 min-1, respectively. From saturation experiments, a Bmax of 304 fmol/mg of protein and a KD of 1.53 nM were calculated. Surprisingly, no appreciable specific binding was observed in this tissue for the alpha-2 agonists [3H]clonidine, [3H]paraminoclonidine and [3H]epinephrine. Inhibition experiments indicated that the binding site had the characteristics of an alpha-2 adrenergic receptor although yohimbine was only 5 times more potent than prazosin. The Ki for epinephrine was decreased 4-fold by 100 microM guanyl-5'-6'-imidodiphosphate suggesting that the receptor binding site may be coupled to adenylate cyclase. Ethanol inhibited the [3H]yohimbine binding with an IC50 of 200 mM. This inhibition was "competitive-like" as increasing concentrations of ethanol resulted in an increased KD, but not a decrease in Bmax. The presence of high density [3H]yohimbine binding sites in early life may have a developmental importance which is not yet understood.
    [Abstract] [Full Text] [Related] [New Search]